Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 33.36%39.76B | 8.81%135.01B | 22.21%38.05B | 36.90%36.34B | 1.77%30.81B | -17.49%29.81B | 48.74%124.08B | 17.15%31.14B | 34.95%26.54B | 87.40%30.27B |
Cost of revenue | 16.72%29.65B | 2.76%112.08B | 4.88%31.31B | 20.04%29.81B | -6.84%25.56B | -5.73%25.41B | 24.57%109.07B | 1.88%29.85B | 43.29%24.83B | 78.16%27.44B |
Gross profit | 129.32%10.11B | 52.71%22.92B | 425.49%6.74B | 281.59%6.53B | 85.14%5.25B | -52.01%4.41B | 463.02%15.01B | 147.08%1.28B | -26.85%1.71B | 276.23%2.83B |
Operating expense | -2.67%1.49B | 18.72%6.43B | 30.90%1.94B | 13.52%1.41B | 17.51%1.55B | 11.49%1.53B | 0.35%5.42B | 3.72%1.48B | -4.46%1.24B | 1.31%1.32B |
Staff costs | 7.21%580M | 18.36%3.53B | 24.54%1.94B | 10.34%512M | 13.03%529M | 11.32%541M | 0.20%2.98B | 1.50%1.56B | 2.43%464M | -3.70%468M |
Selling and administrative expenses | ---- | 10.00%253M | ---- | ---- | ---- | ---- | 21.69%230M | ---- | ---- | ---- |
-General and administrative expense | ---- | 10.00%253M | ---- | ---- | ---- | ---- | 21.69%230M | ---- | ---- | ---- |
Research and development costs | ---- | 5.58%643M | ---- | ---- | ---- | ---- | 14.04%609M | ---- | ---- | ---- |
Rent and land expenses | ---- | -2.34%292M | ---- | ---- | ---- | ---- | -4.17%299M | ---- | ---- | ---- |
Other operating expenses | -8.06%912M | 32.10%1.72B | 1.97%-1.2B | 15.40%899M | 19.98%1.02B | 11.59%992M | -6.48%1.3B | -6.36%-1.22B | -8.14%779M | 4.29%851M |
Operating profit | 199.72%8.61B | 71.89%16.49B | 2,552.04%4.81B | 993.59%5.12B | 144.06%3.7B | -63.20%2.87B | 200.66%9.6B | 95.28%-196M | -54.91%468M | 375.77%1.51B |
Net non-operating interest income (expenses) | 38.10%-39M | -36.09%-230M | 21.67%-47M | -33.33%-52M | -74.36%-68M | -103.23%-63M | -27.07%-169M | -114.29%-60M | 0.00%-39M | -8.33%-39M |
Non-operating interest income | -38.46%8M | -81.05%18M | -66.67%3M | -96.88%1M | -96.43%1M | -50.00%13M | -7.77%95M | -64.00%9M | 23.08%32M | 12.00%28M |
Non-operating interest expense | -38.16%47M | -6.06%248M | -27.54%50M | -25.35%53M | 2.99%69M | 33.33%76M | 11.86%264M | 30.19%69M | 9.23%71M | 9.84%67M |
Net investment income | -53.20%1.18B | 408.14%3.81B | 707.75%1.57B | 16.53%-414M | -4.79%139M | 85.19%2.51B | -10.51%749M | -275.51%-258M | -208.30%-496M | 342.42%146M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 0 | -336.36%-26M | -27.27%8M | 3M | 13M | |||
Income from associates and other participating interests | 30.77%17M | -97.35%24M | -33.33%10M | -105.26%-1M | -99.52%2M | -97.14%13M | 904.44%904M | 400.00%15M | -29.63%19M | 845.45%416M |
Special income (charges) | 500.00%4M | -4,600.00%-47M | 21M | -100.82%-1M | -103.57%-1M | 0 | ||||
Less:Other special charges | ---- | 40.00%-6M | --45M | ---21M | ---- | ---- | 52.38%-10M | ---- | ---- | ---- |
Less:Write off | ---- | -81.82%2M | ---- | ---- | ---- | ---- | 107.24%11M | ---- | ---- | ---- |
Other non-operating income (expenses) | 284.62%24M | -114.64%-41M | -37.50%35M | -115.18%-29M | -17.24%-34M | -120.97%-13M | -37.64%280M | 133.33%56M | 40.44%191M | -151.79%-29M |
Income before tax | 83.92%9.79B | 76.99%20.06B | 1,550.69%6.33B | 3,080.14%4.64B | 86.24%3.76B | -44.55%5.32B | 238.94%11.33B | 89.01%-436M | -91.07%146M | 572.20%2.02B |
Income tax | -95.60%40M | -172.46%-100M | -5,225.00%-2.26B | 862.22%686M | 291.61%560M | 2,117.07%909M | -47.53%138M | -61.74%44M | -309.30%-90M | 550.00%143M |
Net income | 120.88%9.75B | 80.06%20.16B | 1,887.50%8.58B | 1,576.69%3.96B | 70.61%3.2B | -53.82%4.42B | 232.96%11.19B | 88.24%-480M | -85.18%236M | 517.33%1.88B |
Net income continuous operations | 120.88%9.75B | 80.06%20.16B | 1,887.50%8.58B | 1,576.69%3.96B | 70.61%3.2B | -53.82%4.42B | 232.96%11.19B | 88.24%-480M | -85.18%236M | 517.33%1.88B |
Noncontrolling interests | 58M | 202M | 13,900.00%138M | 3,500.00%36M | 0 | -1M | 1M | |||
Net income attributable to the company | 119.57%9.69B | 78.26%19.95B | 1,862.42%8.44B | 1,568.51%3.92B | 69.12%3.18B | -53.82%4.42B | 232.96%11.19B | 88.26%-479M | -85.24%235M | 517.33%1.88B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 119.57%9.69B | 78.26%19.95B | 1,862.42%8.44B | 1,568.51%3.92B | 69.12%3.18B | -53.82%4.42B | 232.96%11.19B | 88.26%-479M | -85.24%235M | 517.33%1.88B |
Gross dividend payment | ||||||||||
Basic earnings per share | 119.35%139.79 | 77.86%287.86 | 1,842.06%121.77 | 1,603.31%56.55 | 69.10%45.81 | -53.96%63.73 | 232.79%161.85 | 88.17%-6.99 | -85.60%3.32 | 515.49%27.09 |
Diluted earnings per share | 119.45%138.65 | 77.97%285.52 | 1,827.90%120.78 | 1,589.76%56.1 | 68.75%45.46 | -53.91%63.18 | 231.63%160.43 | 88.18%-6.99 | -85.59%3.32 | 513.19%26.94 |
Dividend per share | 0 | 300.00%20 | 200.00%15 | 0 | 5 | 0 | 5 | 5 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |